Diseases [C] » Infections [C01] » Bacterial Infections and Mycoses » Bacterial Infections » Gram-Positive Bacterial Infections » Actinomycetales Infections » Mycobacterium Infections » Tuberculosis
Description
Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. MeSH
Hierarchy View
Subtype Terms (8)
Tuberculosis, Multidrug-Resistant
40 drugs (31 approved, 9 experimental)
Tuberculosis, Pulmonary
92 drugs (58 approved, 34 experimental)
Approved Indicated Drugs (21)
Phase 4 Indicated Drugs (49)
Phase 3 Indicated Drugs (32)
Phase 1 Indicated Drugs (41)
Other Experimental Indicated Drugs (22)
Organization Involved with Phase 4 Indications (128)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
All India Institute of Medical Sciences
Bamrasnaradura Infectious Diseases Institute
Bill and Melinda Gates Foundation
Centers for Disease Control and Prevention (CDC)
Central Institute of Epidemiology, Moscow, Russia
Central Research Institute of Epidemiology
Changchun Infectious Disease Hospital
City of Rio De Janeiro Municipal Health Secretariat
Communicable Disease Program, Brazil
Consortium to Respond Effectively to the AIDS/Tuberculosis Epidemic
Drugs for Neglected Diseases Initiative
European and Developing Countries Clinical Trials Partnership (EDCTP)
Federal University of Mato Grosso do Sul
French National Agency for Research on AIDS and Viral Hepatitis
Health Research Board, Ireland
Heilongjiang Province center for tuberculosis Control and Prevention
Hospital Universitario Virgen de las Nieves
Huazhong University of Science and Technology
Infectious Disease Institute, Kampala, Uganda
Infectious Disease Prevention Hospital in Heilongjiang Province
Instituto Nacional de Ciencias Medicas y Nutricion
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Instituto Nacional de Enfermedades Respiratorias
Instituto Nacional de la Nutrición Salvador Zubiran
International Maternal Pediatric Adolescent AIDS Clinical Trials Network
Kaifeng Pulmonary Disease Hospital
Kibong'oto National Tuberculosis Hospital, Sanya Juu, Tanzania
Laboratorios Nacionales de Biológicos y Reactrivos
Mbarara University of Science and Technology
Medical Research Council, The Gambia
National Center for Research Resources (NCRR)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Child Health and Human Development (NICHD)
National Institute of Mental Health (NIMH)
National Institutes of Health (NIH)
People's Liberation Army of China
Public Health Clinical Center of Chengdu
Sixth People's Hospital of Nantong
Sixth People's Hospital of Nanyang City
Sociedad Andaluza de Enfermedades Infecciosas
South African Tuberculosis Vaccine Initiative (SATVI)
Taichung Veterans General Hospital
The 4th People's Hospital of Qinghai Province
The Fifth People's Hospital of Suzhou
The Infectious Disease Hospital of Wangkai Zaozhuang
The Infectious Hospital of Hebi
The Third People's Hospital of Zhenjiang
The University of Texas, Dallas
Tuberculosis Hospital in Jilin Province
United States Agency for International Development
University of California, Los Angeles
University of California, San Francisco
University of Colorado, Denver
University of North Carolina at Chapel Hill
Organization Involved with Phase 3 Indications (217)
Almaty City Tuberculosis Dispensary, Almaty, Kazakhstan
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
A One Hospital, New Delhi, India
Arya Chest Clinic, Meerut, UP,India
Australian Capital Territory Department of Health
Australian National University
Badalona Hospital Germans Trias i Pujol
Canadian Institutes of Health Research (CIHR)
Caprisa eThakwini Research Facility, Durban, South Africa
Case Western Reserve University
Centre for Advanced Lung and Sleep Disorders, New Delhi, India
Centre for the AIDS Programme of Research in South Africa
Chest Disease Institute (CDI), Ministry of Public Health, Nonthaburi
Chiangrai Prachanukroh Hospital
Christian Medical College, Vellore, India
Comprehensive International Program of Research on AIDS
Department of Science and Technology, South Africa
Diligent Hospital, New Delhi, India
District Ministry of Health, Timika
Don McKenzie Hospitals, Kwazulu Natal, South Africa
Doris Goodwin Hospitals, Kwazulu Natal, South Africa
Dr D.K. Chauhan, New Delhi, India
Dr. Mahip Saluja Clinic, Meerut, U.P. India
Dr. Mittal's Clinic, Balaji Medical Store, New Delhi, India
Dr. Neeraj Gupta, Firozabad ,U.P, India
Dr. R. K. Garg's Clinic, U.P, India
Dr. Sanjay Teotia Clinic, Meerut, U.P , India
Dr. SPS Chauhan, Firozabad, U.P-India,
Dr. S. P. Sondhi Clinic , Meerut U.P India
Dr Subodh, Swaroop Nagar,Kanpur, India
Eijkman Institute for Molecular Biology, Jakarta, Indonesia
Fundación para la Investigación Biomédica del Hospital 12 de Octubre
Ganesh Shankar Vidyarthi Memorial Medical College
Global Alliance for TB Drug Development
Guru Tej Bahadur Hospital, Kanpur India
Hackensack University Medical Center
HIV-NAT Thai Red Cross AIDS Research Center
Hospital General de occidente de la secretaria, Seattle, Mexico
Indian Council of Medical Research
Indra Nursing Home and Maternity Centre, Uttar Pradesh, India
Institute of Medical and Veterinary Pathology, South Australia
Institute of Respiratory Medicine, Jalan Pahang, Malaysia
Institute of Tropical Medicine, Belgium
Institut National de la Santé Et de la Recherche Médicale, France
Interactive Research and Development
International Tuberculosis Research Center
Jigyasa Medical Center, Uttar Pradesh, India
Joint Clinical Research Centre, Kampala, Uganda
JSC Scientific Center for Anti-infectious Drugs
Karaganda State Medical University
Karl Bremer Hospital, Cape Town South Africa
Katholieke Universiteit Leuven
Kenya Medical Research Institute
King George's Medical University
Korean Institute of Tuberculosis
Lata Medical Research Foundation, Nagpur, India
Lisichansk Regional Tuberculosis Dispensary
Maharat Nakhon Ratchasima Hospital
Menzies School of Health Research
Mimika District Health Authority
National Center for Tuberculosis and Lung Diseases, Georgia
National Center for Tuberculosis Problems, Kazakhstan
National Health and Medical Research Council, Australia
National Institute for Research in Tuberculosis, Chennai, India
National Institute of Health Research and Development, Jakarta, Indonesia
National Medical University, Ukraine
National TB control Programme Bangladesh
National University of Singapore
New City Hospital and Trauma Centre, Lucknow, India
NIMR - Mbeya Medical Research Programme
Papuan Community Health and Development Foundation
Pham Ngoc Thach University of Medicine
Postgraduate Institute of Medical Education and Research
Prakash Devi Memorial Medical Centre,New Delhi, India
Pulmonary Care and Sleep Clinic, Kanpur, India
Queen Savang Vadhana Memorial Hospital, Thailand
Rajul Nursing Home, Sasni Gate, Aligarh, UP India
Regional Anti-TB Dispensary of Karagandy Oblast, Kazakhstan
Republican Research and Practical Centre for Pulmonology and Tuberculosis
Republican Scientific and Practical Centre for Pulmonology and Tuberculosis hospital
Republican specialised scientific-practical medical centre, Tashkent
Republican TB Hospital No. 2, Nukus
Saanvi MultiSpeciality Clinic, Moradabad
Scientific Center for Anti-infectious Drugs, Kazakhstan
Serum Institute of India Pvt. Ltd.
Siddharth Nursing Home, Agra, U.P India
Soweto Perinatal HIV Research Unit, Johannesburg, South Africa
Sri Venkateswara Institute of Medical Sciences University
Surya Chest Foundation, Lucknow India
TB & HIV Investigative Network (THINK)
Tembisa Hospital, South Africa
The HIV Netherlands Australia Thailand Research Collaboration
The Public Health Centre 28 Krung thon buri
Tropical Diseases Hospital, Ho Chi Minh City
Universidad Complutense de Madrid
University of Medicine and Dentistry of New Jersey
University Teaching Hospital, Lusaka, Zambia
Vakzine Projekt Management GmbH
Varshneya Chest Clinic & Eye Care Centre, Aligarh, UP India
Wits Health Consortium (Pty) Ltd
Organization Involved with Phase 2 Indications (90)
African Poverty Related Infection Oriented Research Initiative
Armauer Hansen Research Institute, Ethiopia
B. J. Medical College and Hospital
Central General Chest Institute
Children's Infectious Diseases Clinical Research Unit, Cape Town
German Federal Ministry of Education and Research
Groupe Haitien d'Etude du Sarcome de Kaposi et des Infections Opportunistes
Infectious Disease Research Institute
International Center for Diarrheal Disease Research
Kharkiv National Medical University
Kumasi Centre for Collaborative Research
Kwame Nkrumah University of Science and Technology
Nanyang Technological University
National Heart, Lung, and Blood Institute (NHLBI)
National Institute for Medical Research, Tanzania
National Institute for Public Health and the Environment, RIVM, Holland
National Institute of Diseases of Chest and Hospital, Dhaka, Bangladesh
Nelson R. Mandela School of Medicine
Shanghai Jiatan Pharmatech Co., Ltd
Shanghai University of Traditional Chinese Medicine
The international Union Against Tuberculosis and Lung Diseases, Paris
The Research Institute of Tuberculosis, Japan
The South African Tuberculosis Vaccine Initiative
Triclinium Clinical Trial Project Management
TuBerculosis Vaccine Initiative
University of California, San Diego
Organization Involved with Phase 1 Indications (35)
Organization Involved with Other Experimental Indications (37)
Bureau of Science and Technology of Guangxi Province, China
Consorcio de Investigación sobre VIH/SIDA/TB
Department of State for Health and Social Welfare, The Gambia
Groupe Hospitalier Paris Saint Joseph
Indonesian Directorate General of Higher Education
Institute of Liver and Biliary Sciences, India
Jawaharlal Institute of Postgraduate Medical Education and Research
Justus Liebig University Giessen
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
